Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial. Laroni A, Brogi D, Brescia Morra V, Guidi L, Pozzilli C, Comi G, Lugaresi A, Turrini R, Raimondi D, Uccelli A, et al. BMC Neurol. 2014 Apr 1; 14(1):65. Epub 2014 Apr 01. PMID: 24690227. Abstract CommentRecommendBookmarkWatch